Upstream Bio Appoints Allison Ambrose as General Counsel
17 déc. 2024 08h00 HE
|
Upstream Bio
Upstream appoints Allison Ambrose as General Counsel
Upstream Bio Announces Addition to Russell 2000® Index
16 déc. 2024 08h00 HE
|
Upstream Bio
Upstream Bio (Nasdaq:UPB) to be added to Russell 2000® index effective at the open of the U.S. equities market on Monday, December 23.
Upstream Bio to Participate in the Piper Sandler 36th Annual Healthcare Conference
21 nov. 2024 08h00 HE
|
Upstream Bio
Upstream Bio CEO to participate in fireside chat at Piper Sandler
Upstream Bio Reports Third Quarter 2024 Financial Results and Recent Business Highlights
07 nov. 2024 07h00 HE
|
Upstream Bio
Upstream reports third quarter 2024 financial results and recent corporate achievements
Upstream Bio Announces Closing of $293 Million Upsized Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
15 oct. 2024 16h15 HE
|
Upstream Bio
Upstream closes $293 million upsized IPO including full exercise of underwriters’ option to purchase additional shares
Upstream Bio Announces Pricing of Upsized Initial Public Offering
10 oct. 2024 19h35 HE
|
Upstream Bio
Upstream Bio announces pricing of upsized initial public offering
Upstream Bio Announces Oral Presentation of New Data from a Phase 1b Multiple Ascending Dose Trial of Verekitug (UPB-101) in Adults with Asthma at the European Respiratory Society Congress
09 sept. 2024 08h00 HE
|
Upstream Bio, Inc.
Upstream gives oral presentation of clinical data for verekitug in patients with severe asthma at European Respiratory Society congress
Upstream Bio Presents Results from a Dose Ranging Study of Verekitug (UPB-101) in Adults with Asthma at the American Thoracic Society International Conference
22 mai 2024 11h15 HE
|
Upstream Bio, Inc.
Positive results from a Phase 1 dose ranging study of verekitug (UPB-101) in asthma presented at ATS 2024
Upstream Bio to Present Results from a Dose Ranging Study of Verekitug (UPB-101) in Adults with Asthma at the American Thoracic Society (ATS) International Conference
15 mai 2024 07h00 HE
|
Upstream Bio, Inc.
Upstream Bio will present clinical data from dose-ranging study of verekitug (UPB-101) in adults with asthma at the American Thoracic Society conference